Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways
Jingwen Wang, Jingyang Zhang, Zhi‐Ling Yu, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102416-102416
Closed Access | Times Cited: 8
Bridging the gap: glucose transporters, Alzheimer’s, and future therapeutic prospects
Mai Albaik, Dalaa Sheikh Saleh, Dana Kauther, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Mitochondrial dysfunction in Alzheimer’s disease: a key frontier for future targeted therapies
Shuguang Wang, Zuning Liao, Qiying Zhang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin
Xingyuan Ma, Chao Sun, Xiao Ding, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Improvements in Exercise for Alzheimer’s Disease: Highlighting FGF21-Induced Cerebrovascular Protection
Juan Wang, Xiangyuan Meng, Yang Jialun, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
Francesca Mancinetti, Dionysios P. Xenos, Michelantonio De Fano, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102018-102018
Closed Access | Times Cited: 16
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism
Waad A. Samman, Salma Selim, Hassan M. El Fayoumi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 753-753
Open Access | Times Cited: 15
Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer’s disease: a narrative review
Xin Jiang, Ji Li, Xiaohui Yao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Lidan Hu, Wenmin Wang, Xiangjun Chen, et al.
Brain‐X (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system
Jiaqi Mei, Yi Li, Liyan Niu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Emerging role of Metformin in Alzheimer’s disease: A translational view
Juvenal A. Ríos, Juan Carlos Bórquez, Juan A. Godoy, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102439-102439
Closed Access | Times Cited: 4
Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
Aparna Chauhan, Sachin Dubey, Smita Jain
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 4
Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation
Sara M Khamies, Mohammed F. El-Yamany, Sherehan M. Ibrahim
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 3
GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review
Mohammad Abubakar, Lokesh Nama, Mohammad Arif Ansari, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1635-1664
Closed Access | Times Cited: 2
Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models
Andreea-Daniela Meca, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarțău, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5929-5949
Open Access | Times Cited: 2
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes and TXNIP-GLUT signaling pathway
Tao Wang, Ling Hao, Kexin Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Emerging roles of epigenetics in lead-induced neurotoxicity
Zongqin Mei, Guofen Liu, Bo Zhao, et al.
Environment International (2023) Vol. 181, pp. 108253-108253
Open Access | Times Cited: 7
Gut microbiome and Alzheimer’s disease: what we know and what remains to be explored
Bhupinder Kapoor, Pratim Biswas, Monica Gulati, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102570-102570
Closed Access | Times Cited: 1
Aging device: tau protein transposes the telomere fragment into promoter/enhancer to promote gene copy number decrement regulation
Wenzhong Liu, Li hualan
(2024)
Open Access | Times Cited: 1
Aging device: tau protein transposes the telomerase fragment into promoter/enhancer to promote gene copy number decrement regulation
Wenzhong Liu, Li hualan
(2024)
Open Access | Times Cited: 1
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Abhinbhen W. Saraya, Chavit Tunvirachaisakul, Chanikarn Sonpee, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of Aβ1-42 and tau through regulation of PI3K/Akt signaling pathway
Kang Chen, Guran Yu
European Journal of Pharmacology (2023) Vol. 962, pp. 176251-176251
Closed Access | Times Cited: 2
Lowering glucose enhances BACE1 activity and Aβ generation in mouse brain slice cultures
Olivia Sheppard, Robert Humphrey, Claire S. Durrant, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
“NO” controversy?: A controversial role in insulin signaling of diabetic encephalopathy
Xi Chen, Ying Song, Hong Ye, et al.
Molecular and Cellular Endocrinology (2024) Vol. 593, pp. 112346-112346
Closed Access
In Vivo and Computational Studies on Sitagliptin’s Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer’s Disease
Vasudevan Mani, Minhajul Arfeen
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1191-1191
Open Access
Page 1 - Next Page

Scroll to top